alan .. this is *classic* .. (comments from *there*) by

New Post Public Reply Private Reply Replies (3) Message Board
4kids AlanC #35491
303
alan ..

this is *classic* .. (comments from *there*) by a mutually coordinated thumbs' downer for both of us *here* ..

Quote:
we have no significant failures to deliver. period. that should be the end of abusive naked short theory. it's not,.... why?


btw this to me is classic troll conditioning .. reason being is that the *assumption*
er .. given .. is that the SEC actually gives a damn about the *transparency* on
any OTC stock that still exists ( survives ) due to originally coming public via a R/M into a previously used *shell* for a company that already was exterminated

note the OTC stox that have come public via S1 Registrations .. do *trigger* FTDs

as a reminder for those observing this ping pong match .. this is what the SEC
notes re: FTDs (failures to deliver re: what is termed hard locates .. in other words *shares*)

Pursuant to Rule 203(b)(3) of Regulation SHO and FINRA Rule 4320, a participant of a registered clearing agency (i.e., a clearing firm), that has a fail to deliver position at a registered clearing agency (i.e., National Securities Clearing Corporation) in a Threshold Security for 13 consecutive settlement days must immediately close out that fail to deliver position by purchasing shares of like kind and quantity . (Please click the below Information icon for more details about the Threshold Security).


http://otce.finra.org/RegSHO


and of course this ..

REG SHO Overview

As defined in Rule 203(c)(6) of Regulation SHO, a “threshold security” is any equity security of any issuer that is registered under Section 12 of the Exchange Act, or that is required to file reports under Section 15(d) of the Exchange Act (commonly referred to as reporting securities), where, for five consecutive settlement days:

There are aggregate fails to deliver at a registered clearing agency of 10,000 shares or more per security;
The level of fails is equal to at least one-half of one percent of the issuer’s total shares outstanding; and
The security is included on a list published by a self-regulatory organization (SRO).

A security ceases to be a threshold security if it does not exceed the specified level of fails for five consecutive settlement days .

rule 203 pertains to any company that is fully compliant .. ie they file (which of
course is Innovation Pharma)

4320 pertains to those OTC companies that *selectively* file .. in other words
not IPIX (or CTIX) which is/are OTCQB .. and if one wants to think of it this way
the more transparent .. the more *stress* is revealed which is why hedge funds
and their minions don't want this data *understood* .. because it isn't rocket science
but in the aggregate NR (non retail) can only roll an IOU so long with mgmt's
ability to execute .. (outlast them) .. reminder NR is used to controlling outcomes
when it comes to OTC stox .. (usually poorly watched with less than aware
mgmt teams)

i've shown since 5.10.17's incredibly stupid 52 week low *reset* .. by NR
just how revealing NRs' *stress* is since then .. or as i call it their *struggle*


( edit .. to save another post ... it's also why NR has had to morph up the *legal*
short since the EO April 2017 on IPIX/CTIX from approx 800,000 to 1.2M~)

and because the vehicle of choice doesn't allow for back and forth to *show*
what is done on other OTC stox .. this ? can't be asked back to mr. thumbs down

how is it a fully compliant OTCQB stock that came public via an S1 Registration
in April 2015 .. has triggered 7 rounds (mark my words since i do know this stuff
8th is en route *shortly* pun intended) .. since the EO April 2015 .. (4 in 2015
and 3 *so far* in 2017)


the board there .. like all
of that site's *boards* is littered with trolls .. pushing in this case .. the negative
because of course actual *shares* are needed and how is it of those 7 rounds
of FTDs (last one ended last month) .. that 13 days came and went ..
sans *buy ins* as is supposed to be *done* as noted by the SEC .. .. for at
least 3 of those 7 rounds .. which had 17 .. 19 and 23 days of FTDs

yeah .. the SEC isn't worth the paper their *mandate* is written on .. because
they are a paper tiger

as for the vehicle of choice for OTC stock manipulation .. it's a beyond *clever*
TOU utilized to suit which ever *side* .. .. of NRs' cycles of money .. is needed

NR works cycles of money both UP and DOWN

btw .. here's why we both can see *stress* in play since 5.10.2017 on IPIX ..

reminder .. of what *avgs* showed then .. cause volume also matters in conjunction with what the daily tape of trades' reveals

====

Detailed Quote:CTIX
CELLCEUTIX CORPORATION
0.66Down -0.005 (-0.75 %)AS OF 3:57:19PM ET 05/10/2017


Last Trade 0.66
Trade Time 3:57:19pm ET

Change -0.005
% Change -0.75%


Open 0.656
Day High 0.67
Day Low 0.63 ** 52 week low reset again
Previous Close
05/09/2017 0.665

52-Week High
05/24/2016 1.73

52-Week Low
05/10/2017 0.63


Price Performance (Last 52 Weeks)
05/09/2017 -59.20%


Volume 354,688 * vol done in a tightly held 4c *pps range* ..
Volume (10 day Average) 139,522 ** note prior 10 days' *efforts* on less vol
Volume (90 day Average) 278,652


ok and here's what *stress* looks like from NRs' POV .. count the days over 30%
(reminder this site does not include t trades .. which bypass daily reg sho %s)

since ticker/cusip change out (good job Leo) .. 13 out of 15 trading days ..
that is 86.66%

Historical Short Volume Data for IPIX
 Date	Close	High	Low	Volume	Sht Vol	% of Vol Shtd 


 Jun 29	NA	NA	NA	357,758	63,054	17.62% 
Jun 28 NA NA NA 402,068 170,154 42.32%
Jun 27 NA NA NA 339,385 141,570 41.71%
Jun 26 NA NA NA 719,890 449,916 62.50%
Jun 23 NA NA NA 272,027 98,558 36.23%
Jun 22 NA NA NA 191,579 64,301 33.56%
Jun 21 NA NA NA 284,072 155,270 54.66%
Jun 20 NA NA NA 188,080 100,264 53.31%
Jun 19 NA NA NA 112,174 34,556 30.81%
Jun 16 NA NA NA 287,610 103,325 35.93%

Jun 15 NA NA NA 224,876 54,557 24.26%
Jun 14 NA NA NA 840,035 271,279 32.29%
Jun 13 NA NA NA 181,406 83,288 45.91%
Jun 12 NA NA NA 470,434 145,836 31.00%
Jun 09 NA NA NA 133,755 54,956 41.09%


and b4 that .. just from the *last reset* .. 13 of 21 *trading* days ( 61.90% )


Historical Short Volume Data for CTIX

 Date	Close	High	Low	Volume	Sht Vol	% of Vol Shtd 


 
Jun 08 NA NA NA 409,247 141,580 34.60%
Jun 07 NA NA NA 146,839 73,961 50.37%
Jun 06 NA NA NA 333,855 80,471 24.10%
Jun 05 NA NA NA 179,944 35,587 19.78%
Jun 02 NA NA NA 265,751 64,719 24.35%
Jun 01 NA NA NA 399,456 154,521 38.68%

May 31 NA NA NA 191,959 32,102 16.72%
May 30 NA NA NA 217,484 29,632 13.62%
May 26 NA NA NA 292,116 71,544 24.49%
May 25 NA NA NA 274,005 99,539 36.33%
May 24 NA NA NA 454,447 225,351 49.59%
May 23 NA NA NA 607,936 270,190 44.44%
May 22 NA NA NA 327,770 181,148 55.27%
May 19 NA NA NA 213,550 110,861 51.91%
May 18 NA NA NA 106,762 24,699 23.13%
May 17 NA NA NA 62,403 22,410 35.91%
May 16 NA NA NA 453,269 176,254 38.89%

May 15 NA NA NA 547,948 224,198 40.92%
May 12 NA NA NA 202,384 78,408 38.74%
May 11 NA NA NA 84,656 15,500 18.31%
May 10 NA NA NA 354,688 161,021 45.40%


btw here's what Friday's data showed .. for avgs and YOY .. note the 90 day avgs
for almost 3 months ago vs last trading .. 10 day avgs are much easier to *work*


Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.9599Up 0.0099 (1.04 %)AS OF 3:54:35PM ET 06/30/2017


Last Trade 0.9599
Trade Time 3:54:35pm ET

Change 0.0099
% Change 1.04%


Open 0.935
Day High 0.96
Day Low 0.905
Previous Close
06/29/2017 0.95

52-Week High
11/22/2016 1.505

52-Week Low
05/10/2017 0.63


Price Performance (Last 52 Weeks)
06/29/2017 -29.10%


Volume 114,484
Volume (10 day Average) 316,297 ** ..
Volume (90 day Average) 274,545



just me perhaps ..since i believe NR *perverts* stats they have to report (they
are called *SROs* for a reason .. stands for self regulating) on many OTC co.s
that have come public via a R/M .. i actually expect FTDs to have to be *reported*
on IPIX in the back half of 2017 ..

which will shut up some and create others *there* .. interchangeables reign

but educated retail investors (respective caveats met) can both outlast and
work off of NRs' *efforts* ..

hope your weekend is going well ..

4kids


















1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rural Hospitals Face Shaky Future; Warbird RCM Steps In

Updated Category News Views 3

Revamping Revenue Cycle Management for Rural Healthcare In a world that's increasingly teetering on the delicate tightrope of balance sheets, Warbird Healthcare Advisors is stepping into the ring with fists up, ready to fight for rural hospitals. Introducing their latest venture, Warbird RCM Partners, they're honing in on revenue cycle management and billing services to...

Continue Reading
When Families Should Consider Life Insurance Plans

Updated Category News Views 4

Let’s talk about why life insurance isn’t just for those walking around with gray hair. K.D. the Insurance Queen from Centennial, Colorado, dishes out the clearest advice on when and why families ought to have it in their arsenal. A New Mindset on Life Insurance Some folks out there think life insurance is something you ponder in your twilight years. But here’s the...

Continue Reading
Critical Questions to Ask When Buying Life Insurance

Updated Category News Views 3

Getting Under the Hood of Life Insurance Alright, so you're thinking about life insurance. Not exactly a day at the beach, but it’s one of those crucial life things to nail down. Paula Miller, a savvy insurance pro, walks through what to consider before you just slap down a signature and hope for the best. The Basics: Policy Types and Coverage Life insurance can be as...

Continue Reading
Centrus Energy to Discuss Q3 Earnings on Nov 5 Call

Updated Category News Views 7

Centrus Energy Prepares for Earnings Call You ever feel that twinge in your gut right before a big disclosure? Well, that's where Centrus Energy’s about to take us as they gear up for their quarterly earnings call. On November 5th, bright and early at 8:30 a.m. Eastern Time, NYSE:LEU will be in the spotlight, laying out its Q3 results for all us nose-to-the-grindstone...

Continue Reading
Ellington's Q3 Earnings Call: What Investors Need to Know

Updated Category News Views 5

An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...

Continue Reading
Podium Surges Past $150M in AI ARR Milestone

Updated Category News Views 8

A New Era for Podium When the brass at Podium made a gamble on AI, they didn't just try squeezing it into their old business model. Oh no, they launched what feels like a startup within their existing empire—no half-measures, just full-throttle ambition. Fast forward two and a half years, and they've racked up over $150 million in annual recurring revenue from these...

Continue Reading
Harbour BioMed's Batoclimab Injected Into Myasthenia Market

Updated Category News Views 5

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...

Continue Reading
Gillis Joins McGinnis Lochridge as COO Amid Firm's Milestone

Updated Category News Views 6

An Experienced Executor at the Helm Now, here's a story that rings of continuity meeting change. McGinnis Lochridge, a staple of the Texas legal scene since 1927, has tapped Charles Gillis to take charge as their Chief Operating Officer. You'd think they're gearing up to celebrate a hundred years by shaking things up internally. Why not bring in someone seasoned, I say?...

Continue Reading
Dott's Q3 2026: Micromobility Growth Soars High

Updated Category News Views 5

Riding the Wave of Profit in Micromobility Sometimes all you need is a quick jolt of genius to turn the wheels of fortune. Dott seems to have hit that sweet spot in Q3 of 2026. Deploying 45,000 new vehicles wasn’t just a logistical feat; it was a calculated bet that paid off handsomely, bolstering their business to soaring heights. Performance that Packs a Punch The Q3...

Continue Reading
NYC's Carriage Horse Ban: A New Era for Urban Welfare

Updated Category News Views 4

You've got to hand it to New York City—this isn't just another Tuesday twist. The City Council's decision to nix horse-drawn carriages is like throwing a wrench in an antique machine. It's a bold move in a concrete jungle that's constantly wearing new coats. Tradition vs. Welfare: The Crux For years, the idea of horses prancing down NYC streets seemed like a quaint nod...

Continue Reading

Top 5 Most Recently Viewed Articles

KBR Secures $85 Million Contract for Essential Airfield Supplies

Updated Category News Views 252

KBR Secures Major Contract for Airfield Repair Solutions KBR (NYSE: KBR) has proudly announced that it has clinched a firm fixed-price contract worth $85 million with the U.S. Air Force. This contract focuses on the procurement, design, and delivery of essential training aids along with airfield damage repair kits around the globe. This operational venture falls under the...

Continue Reading
Medianet Unveils Comprehensive Platform for Media Intelligence

Updated Category News Views 138

Medianet got ready to launch its innovative media intelligence platform back in 2024, aiming to integrate various media services into a single seamless experience. This isn't just some run-of-the-mill upgrade; this is the kind of game-changer that could rattle competitors who’ve grown too comfortable in their foreign-owned thrones. Game-Changer Alert: Medianet’s...

Continue Reading
Visa Set to Reveal Q1 2025 Financials on January 30

Updated Category News Views 174

Visa Set to Announce Fiscal Q1 2025 Financial Results Visa (NYSE: V) is preparing to unveil its financial results for the first quarter of fiscal 2025. This much-anticipated announcement will take place on January 30, 2025, following the market’s closure. As per tradition, the company will file the details with the Securities and Exchange Commission and will provide the...

Continue Reading
EHang's Upcoming Financial Results and Innovations in Air Mobility

Updated Category News Views 171

EHang Holdings Limited Set to Announce Financial Results GUANGZHOU, China — EHang Holdings Limited (Nasdaq: EH), renowned for its pioneering Urban Air Mobility (UAM) technology, is preparing to unveil its financial results for the second quarter. Conference Call Details The company's earnings announcement is scheduled for Tuesday, ahead of the U.S. market opening. This...

Continue Reading
Real Estate Sales Trends: What August's Data Revealed

Updated Category News Views 221

Understanding August's Existing-Home Sales Trends Recent reports indicate that existing-home sales in August showed a slight decline of 0.2% compared to July. This data highlights the evolving landscape of the real estate market. The National Association of REALTORS® (NAR) provided insights into the current conditions affecting homebuyers and sellers, including...

Continue Reading
ection End -->